MMC vs ORMP
Marsh & McLennan Companies Inc (MMC) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MMC and ORMP stock pages for the full models.
Not investment advice.